메뉴 건너뛰기




Volumn 11, Issue 2, 2013, Pages 60-66

Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone

Author keywords

Aripiprazole; Cognition; Prolactin; Risperidone; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; PLACEBO; RISPERIDONE;

EID: 84883618908     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2013.11.2.60     Document Type: Article
Times cited : (36)

References (35)
  • 1
    • 39049174296 scopus 로고    scopus 로고
    • Cognitive impairment and functional outcome in schizophrenia and bipolar disorder
    • Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006; 67:e12.
    • (2006) J Clin Psychiatry , vol.67
    • Green, M.F.1
  • 2
    • 34447546649 scopus 로고    scopus 로고
    • A 12-week, double-blind, placebo- controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia
    • Lee BJ, Lee JG, Kim YH. A 12-week, double-blind, placebo- controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. J Psychopharmacol 2007;21:421-427.
    • (2007) J Psychopharmacol , vol.21 , pp. 421-427
    • Lee, B.J.1    Lee, J.G.2    Kim, Y.H.3
  • 3
    • 33846986313 scopus 로고    scopus 로고
    • A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia
    • Lee SW, Lee JG, Lee BJ, Kim YH. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia. Int Clin Psychopharmacol 2007;22:63-68.
    • (2007) Int Clin Psychopharmacol , vol.22 , pp. 63-68
    • Lee, S.W.1    Lee, J.G.2    Lee, B.J.3    Kim, Y.H.4
  • 4
    • 84863429650 scopus 로고    scopus 로고
    • Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: A placebo-controlled pilot study
    • Lee JG, Lee SW, Lee BJ, Park SW, Kim GM, Kim YH. Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study. Psychiatry Investig 2012;9:166-173.
    • (2012) Psychiatry Investig , vol.9 , pp. 166-173
    • Lee, J.G.1    Lee, S.W.2    Lee, B.J.3    Park, S.W.4    Kim, G.M.5    Kim, Y.H.6
  • 5
    • 84855866544 scopus 로고    scopus 로고
    • Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: A randomized double-blind placebo-controlled trial
    • Shim JC, Jung DU, Jung SS, Seo YS, Cho DM, Lee JH, et al. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology 2012;37:660-668.
    • (2012) Neuropsychopharmacology , vol.37 , pp. 660-668
    • Shim, J.C.1    Jung, D.U.2    Jung, S.S.3    Seo, Y.S.4    Cho, D.M.5    Lee, J.H.6
  • 7
    • 21244448316 scopus 로고    scopus 로고
    • A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
    • DOI 10.1017/S146114570500516X
    • Woodward ND, Purdon SE, Meltzer HY, Zald DH. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 2005;8:457-472. (Pubitemid 41002500)
    • (2005) International Journal of Neuropsychopharmacology , vol.8 , Issue.3 , pp. 457-472
    • Woodward, N.D.1    Purdon, S.E.2    Meltzer, H.Y.3    Zald, D.H.4
  • 8
    • 39649124515 scopus 로고    scopus 로고
    • Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: Recent developments and current perspectives
    • DOI 10.1097/jcp.0b013e31815ac4e5, PII 0000471420071200000013
    • Byerly M, Suppes T, Tran QV, Baker RA. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. J Clin Psychopharmacol 2007;27:639-661. (Pubitemid 351339452)
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.6 , pp. 639-661
    • Byerly, M.1    Suppes, T.2    Tran, Q.-V.3    Baker, R.A.4
  • 11
    • 53549119665 scopus 로고    scopus 로고
    • Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors
    • Tadori Y, Forbes RA, McQuade RD, Kikuchi T. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. Eur J Pharmacol 2008;597:27-33.
    • (2008) Eur J Pharmacol , vol.597 , pp. 27-33
    • Tadori, Y.1    Forbes, R.A.2    McQuade, R.D.3    Kikuchi, T.4
  • 14
    • 0346096591 scopus 로고    scopus 로고
    • In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function
    • DOI 10.1016/j.ejphar.2003.10.025
    • Jordan S, Koprivica V, Dunn R, Tottori K, Kikuchi T, Altar CA. In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. Eur J Pharmacol 2004;483:45-53. (Pubitemid 38056603)
    • (2004) European Journal of Pharmacology , vol.483 , Issue.1 , pp. 45-53
    • Jordan, S.1    Koprivica, V.2    Dunn, R.3    Tottori, K.4    Kikuchi, T.5    Altar, C.A.6
  • 15
    • 58449126907 scopus 로고    scopus 로고
    • Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study
    • APLUS Study Group
    • Kwon JS, Jang JH, Kang DH, Yoo SY, Kim YK, Cho SJ; APLUS Study Group. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study. Psychiatry Clin Neurosci 2009;63:73-81.
    • (2009) Psychiatry Clin Neurosci , vol.63 , pp. 73-81
    • Kwon, J.S.1    Jang, J.H.2    Kang, D.H.3    Yoo, S.Y.4    Kim, Y.K.5    Cho, S.J.6
  • 16
    • 2942551105 scopus 로고    scopus 로고
    • Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain
    • DOI 10.1016/j.ejphar.2004.04.028, PII S0014299904004133
    • Li Z, Ichikawa J, Dai J, Meltzer HY. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 2004;493:75-83. (Pubitemid 38746934)
    • (2004) European Journal of Pharmacology , vol.493 , Issue.1-3 , pp. 75-83
    • Li, Z.1    Ichikawa, J.2    Dai, J.3    Meltzer, H.Y.4
  • 18
    • 70349811302 scopus 로고    scopus 로고
    • Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia
    • Kim SW, Shin IS, Kim JM, Lee JH, Lee YH, Yang SJ, et al. Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia. Clin Neuropharmacol 2009;32:243-249.
    • (2009) Clin Neuropharmacol , vol.32 , pp. 243-249
    • Kim, S.W.1    Shin, I.S.2    Kim, J.M.3    Lee, J.H.4    Lee, Y.H.5    Yang, S.J.6
  • 20
    • 77749252648 scopus 로고    scopus 로고
    • Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone
    • Riedel M, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, Opgen-Rhein M, et al. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone. Hum Psychopharmacol 2010;25:116-125.
    • (2010) Hum Psychopharmacol , vol.25 , pp. 116-125
    • Riedel, M.1    Schennach-Wolff, R.2    Musil, R.3    Dehning, S.4    Cerovecki, A.5    Opgen-Rhein, M.6
  • 21
    • 78650960469 scopus 로고    scopus 로고
    • An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia
    • Suzuki H, Gen K, Inoue Y. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:161-168.
    • (2011) Prog Neuropsychopharmacol Biol Psychiatry , vol.35 , pp. 161-168
    • Suzuki, H.1    Gen, K.2    Inoue, Y.3
  • 22
    • 72849140996 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy
    • Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, et al. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. J Clin Psychiatry 2009;70:1348-1357.
    • (2009) J Clin Psychiatry , vol.70 , pp. 1348-1357
    • Kane, J.M.1    Correll, C.U.2    Goff, D.C.3    Kirkpatrick, B.4    Marder, S.R.5    Vester-Blokland, E.6
  • 23
    • 84862137385 scopus 로고    scopus 로고
    • Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients
    • Yasui-Furukori N, Kaneda A, Sugawara N, Tomita T, Kaneko S. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients. J Psychopharmacol 2012;26:806-812.
    • (2012) J Psychopharmacol , vol.26 , pp. 806-812
    • Yasui-Furukori, N.1    Kaneda, A.2    Sugawara, N.3    Tomita, T.4    Kaneko, S.5
  • 24
    • 34548307179 scopus 로고    scopus 로고
    • The diagnostic and statistical manual of mental disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation
    • DOI 10.1111/j.1743-6109.2007.00557.x
    • Shabsigh R, Rowland D. The Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation. J Sex Med 2007;4:1468-1478. (Pubitemid 47337696)
    • (2007) Journal of Sexual Medicine , vol.4 , Issue.5 , pp. 1468-1478
    • Shabsigh, R.1    Rowland, D.2
  • 25
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276. (Pubitemid 18039085)
    • (1987) Schizophrenia Bulletin , vol.13 , Issue.2 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 26
    • 20444376911 scopus 로고    scopus 로고
    • Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
    • DOI 10.1016/j.schres.2005.02.013, PII S0920996405000782
    • Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res 2005;76:247-265. (Pubitemid 40804771)
    • (2005) Schizophrenia Research , vol.76 , Issue.2-3 , pp. 247-265
    • Chouinard, G.1    Margolese, H.C.2
  • 27
    • 34648833682 scopus 로고    scopus 로고
    • Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: A placebo-controlled trial
    • DOI 10.1176/appi.ajp.2007.06071075
    • Shim JC, Shin JG, Kelly DL, Jung DU, Seo YS, Liu KH, et al. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. Am J Psychiatry 2007;164:1404-1410. (Pubitemid 47461141)
    • (2007) American Journal of Psychiatry , vol.164 , Issue.9 , pp. 1404-1410
    • Shim, J.-C.1    Shin, J.-G.K.2    Kelly, D.L.3    Jung, D.-U.4    Seo, Y.-S.5    Liu, K.-H.6    Shon, J.-H.7    Conley, R.R.8
  • 28
    • 58249085773 scopus 로고    scopus 로고
    • Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study
    • Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study. Schizophr Res 2009;107:218-222.
    • (2009) Schizophr Res , vol.107 , pp. 218-222
    • Byerly, M.J.1    Marcus, R.N.2    Tran, Q.V.3    Eudicone, J.M.4    Whitehead, R.5    Baker, R.A.6
  • 29
    • 78649506539 scopus 로고    scopus 로고
    • Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics
    • Chen CK, Huang YS, Ree SC, Hsiao CC. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34:1495-1499.
    • (2010) Prog Neuropsychopharmacol Biol Psychiatry , vol.34 , pp. 1495-1499
    • Chen, C.K.1    Huang, Y.S.2    Ree, S.C.3    Hsiao, C.C.4
  • 30
    • 77957252761 scopus 로고    scopus 로고
    • Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia
    • Yasui-Furukori N, Furukori H, Sugawara N, Fujii A, Kaneko S. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. J Clin Psychopharmacol 2010;30:596-599.
    • (2010) J Clin Psychopharmacol , vol.30 , pp. 596-599
    • Yasui-Furukori, N.1    Furukori, H.2    Sugawara, N.3    Fujii, A.4    Kaneko, S.5
  • 31
    • 68949212290 scopus 로고    scopus 로고
    • Aripiprazole: Dose-response relationship in schizophrenia and schizoaffective disorder
    • Mace S, Taylor D. Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder. CNS Drugs 2009;23:773-780.
    • (2009) CNS Drugs , vol.23 , pp. 773-780
    • Mace, S.1    Taylor, D.2
  • 32
    • 77954354233 scopus 로고    scopus 로고
    • The staging model in schizophrenia, and its clinical implications
    • Agius M, Goh C, Ulhaq S, McGorry P. The staging model in schizophrenia, and its clinical implications. Psychiatr Danub 2010;22:211-220.
    • (2010) Psychiatr Danub , vol.22 , pp. 211-220
    • Agius, M.1    Goh, C.2    Ulhaq, S.3    McGorry, P.4
  • 33
    • 79952815943 scopus 로고    scopus 로고
    • Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder
    • Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 2011;41:225-241.
    • (2011) Psychol Med , vol.41 , pp. 225-241
    • Lewandowski, K.E.1    Cohen, B.M.2    Ongur, D.3
  • 34
    • 84857235422 scopus 로고    scopus 로고
    • Hierarchical structure of the cognitive processes in schizophrenia: The fundamental role of processing speed
    • Ojeda N, Peña J, Schretlen DJ, Sánchez P, Aretouli E, Elizagárate E, et al. Hierarchical structure of the cognitive processes in schizophrenia: the fundamental role of processing speed. Schizophr Res 2012;135:72-78.
    • (2012) Schizophr Res , vol.135 , pp. 72-78
    • Ojeda, N.1    Peña, J.2    Schretlen, D.J.3    Sánchez, P.4    Aretouli, E.5    Elizagárate, E.6
  • 35
    • 47749140753 scopus 로고    scopus 로고
    • Metabolism of atypical antipsychotics: Involvement of cytochrome P450 enzymes and relevance for drug-drug interactions
    • DOI 10.2174/138920008784746373
    • Urichuk L, Prior TI, Dursun S, Baker G. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab 2008;9:410-418. (Pubitemid 352025195)
    • (2008) Current Drug Metabolism , vol.9 , Issue.5 , pp. 410-418
    • Urichuk, L.1    Prior, T.I.2    Dursun, S.3    Baker, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.